nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2013-17-5-27-34nefr-438Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПРОБЛЕМЫ БИОСОВМЕСТИМОСТИ ДИАЛИЗНОЙ ТЕРАПИИBIOCOMPATIBILITY PROBLEMS OF DIALYSIS THERAPYЛитвиновА. С.LitvinovA. S.

г. Ростов-на-Дону, пр. 40 лет Победы, д. 210. Тел. 8 (863) 302-02-97

leetwin@yandex.ruБатюшинМ. М.BatyushinM. M.

Кафедра внутренних болезней с основами физиотерапии №2

ЛитвиноваЛ. И.LitvinovaL. I.

Кафедра внутренних болезней с основами физиотерапии №2

ПоганеваВ. Н.PoganevaV. N.Ростовский амбулаторный диализный центр «Ростов-Дон»Russian FederationРостовский государственный медицинский университетRussian Federation2013100520131752734Copyright © Литвинов А.С., Батюшин М.М., Литвинова Л.И., Поганева В.Н., 20132013Литвинов А.С., Батюшин М.М., Литвинова Л.И., Поганева В.Н.Litvinov A.S., Batyushin M.M., Litvinova L.I., Poganeva V.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/438

В статье рассматриваются представления о биологической совместимости современных полимерных материалов. Особое внимание уделено биосовместимости полимерных диализных мембран, их воздействию на систему гемостаза и выживаемость пациентов на гемодиализе. Рассмотрены некоторые перспективные подходы к созданию и использованию композитных и полимерных материалов для гемодиализа.

Contemporary submission about biocompatibility of modern polymer materials are considered in this article. Special attention paid to the biocompatibility of polymer dialysis membranes, their impact on hemostasis and patient’s survival on hemodialysis. There are descried perspective areas of creation and using composite and polymer materials for hemodialysis.

гемодиализполимерымембраныхроническая болезнь почекперитонеальный диализбиосовмеcтимостьhemodialysispolymersdialysis membraneschronic kidney diseaseperitoneal dialysisbiocompatibilityReferencesAntisoner RH. Biomaterials science: an introduction to materials in medicine. CA: Academic Press, San Diego, 2004; 5–69Antisoner RH. Biomaterials science: an introduction to materials in medicine. CA: Academic Press, San Diego, 2004; 5–69Brodbeck K, Neubauer M, Schnitzer S, Dietrich R, Hulko M, Krause B. Real-time PCR as a new in vitro biocompatibility method to measure leukocyte response to surface contact in dialysis filter devices. Int J Artif Organs 2013; 36 (4): 240–250Brodbeck K, Neubauer M, Schnitzer S, Dietrich R, Hulko M, Krause B. Real-time PCR as a new in vitro biocompatibility method to measure leukocyte response to surface contact in dialysis filter devices. Int J Artif Organs 2013; 36 (4): 240–250Bruck SD. Biomaterials. Med Dev Art Organs 1973; (1): 65–79Buemi M, Coppolini G, Bolignano D. Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. Ren Fail 2009; (31): 75–80Bruck SD. Biomaterials. Med Dev Art Organs 1973; (1): 65–79Buemi M, Coppolini G, Bolignano D. Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. Ren Fail 2009; (31): 75–80Caballo C, Palomo M, Cases A, Galán AM, Molina P, Vera M, Bosch X, Escolar G, Diaz-Ricart M. NFκB in the development of endothelial activation and damage in uremia: an in vitro approach. PLoS One 2012; 7 (8): 65–84Caballo C, Palomo M, Cases A, Galán AM, Molina P, Vera M, Bosch X, Escolar G, Diaz-Ricart M. NFκB in the development of endothelial activation and damage in uremia: an in vitro approach. PLoS One 2012; 7 (8): 65–84Chadi S, Iskandar B, Yorg Al A, Ali N, Marc S, Suzanne El, Sayegh. Relationship between platelet count and hemodialysis membranes.Int J Nephrol Renovasc Dis 2013; (6): 143–147Chadi S, Iskandar B, Yorg Al A, Ali N, Marc S, Suzanne El, Sayegh. Relationship between platelet count and hemodialysis membranes.Int J Nephrol Renovasc Dis 2013; (6): 143–147Chen HA, Wang JJ, Chou CT, et al. Predictors of longterm mortality in patients with and without systemic lupus erythematosus on maintenance dialysis: a comparative study. J Rheumatol 2011; (38): 2390–2394Chen HA, Wang JJ, Chou CT, et al. Predictors of longterm mortality in patients with and without systemic lupus erythematosus on maintenance dialysis: a comparative study. J Rheumatol 2011; (38): 2390–2394Davenport A. Pyrexia of unknown origin in a haemodialysis patient. NDT Plus 2008; Vol. 2 (3): 76–89Davenport A. Pyrexia of unknown origin in a haemodialysis patient. NDT Plus 2008; Vol. 2 (3): 76–89De Prada L, Lee J, Gillespie A, Benjamin J. Thrombocytopenia associated with one type of polysulfone hemodialysis membrane: a report of 5 cases. Am J Kidney Dis 2013 Jan; 61(1): 131–133De Prada L, Lee J, Gillespie A, Benjamin J. Thrombocytopenia associated with one type of polysulfone hemodialysis membrane: a report of 5 cases. Am J Kidney Dis 2013 Jan; 61(1): 131–133Désormeaux A, Moreau ME, Lepage Y, Chanard J, Adam A. The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Am J Kidney Dis 2007; May 49 (5): 642–649Désormeaux A, Moreau ME, Lepage Y, Chanard J, Adam A. The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Am J Kidney Dis 2007; May 49 (5): 642–649Eds B Ratner, Hiffman AS, Schoen FJ, Lemon JE. Biomaterials science: an introduction to materials in medicine, 2nd ed. CA: Academic Press, San Diego, 2004; 851Eds B Ratner, Hiffman AS, Schoen FJ, Lemon JE. Biomaterials science: an introduction to materials in medicine, 2nd ed. CA: Academic Press, San Diego, 2004; 851Evenepoel P, Dejagere T, Verhamme P, Claes K, Kuypers D, Bammens B, Vanrenterghem Y. Heparin-coated polyacryloni trile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. Biomaterial 2005; Apr; 26 (12): 1437-1444Evenepoel P, Dejagere T, Verhamme P, Claes K, Kuypers D, Bammens B, Vanrenterghem Y. Heparin-coated polyacryloni trile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. Biomaterial 2005; Apr; 26 (12): 1437-1444Ficheux A, Gayrard N, Szwarc I, Andress D, Soullier S, Duny Y, Goubert G, Thomas M, Bismuth-Mondolfo J, Daurès JP, Brunet P, Servel MF, Argilés A. The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis. Nephrol Dial Transplant 2011; 26 (7): 2281-2289Ficheux A, Gayrard N, Szwarc I, Andress D, Soullier S, Duny Y, Goubert G, Thomas M, Bismuth-Mondolfo J, Daurès JP, Brunet P, Servel MF, Argilés A. The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis. Nephrol Dial Transplant 2011; 26 (7): 2281-2289Hayashi K, Fukumura H, Yoshikava S, et al. Kobunshi Robunshu. Chem Abstrs 1987; 44 (12): 917–924Hayashi K, Fukumura H, Yoshikava S, et al. Kobunshi Robunshu. Chem Abstrs 1987; 44 (12): 917–924Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients. Caspian J Intern Med 2013; 4 (1): 611–616Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients. Caspian J Intern Med 2013; 4 (1): 611–616Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Intern Med 2011; (2): 205–112Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Intern Med 2011; (2): 205–112Heidari B. The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease. Caspian J Intern Med 2012; (3): 428–435Heidari B. The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease. Caspian J Intern Med 2012; (3): 428–435Heidari B. Undifferentiated arthritis: predictive factors of persistent arthritis and treatment decisions. Caspian J Intern Med 2010; (1): 79–88Heidari B. Undifferentiated arthritis: predictive factors of persistent arthritis and treatment decisions. Caspian J Intern Med 2010; (1): 79–88Knezevic MZ, Djordjevic VV, Radovanovic-Velickovic RM, Stankovic JJ, Cvetkovic TP, Djordjevic VM. Influence of dialysis modality and membrane flux on quality of life in hemodialysis patients. Ren Fail 2012; 34 (7): 849-855Knezevic MZ, Djordjevic VV, Radovanovic-Velickovic RM, Stankovic JJ, Cvetkovic TP, Djordjevic VM. Influence of dialysis modality and membrane flux on quality of life in hemodialysis patients. Ren Fail 2012; 34 (7): 849-855Lee KS, van Holsbeeck MT, Abbud A. Atypical rapid progression of osteoarticular amyloidosis involving the hip in a patient on hemodialysis usingpolyacrylonitrile membranes. Biomaterials 2008; 29 (9): 1139-1146Lee KS, van Holsbeeck MT, Abbud A. Atypical rapid progression of osteoarticular amyloidosis involving the hip in a patient on hemodialysis usingpolyacrylonitrile membranes. Biomaterials 2008; 29 (9): 1139-1146Liu TY, Lin WC, Huang LY, Chen SY, Yang MC. Hemocompatibility and anaphylatoxin formation of protein-immobilizing polyacrylonitrile hemodialysis membrane. Skeletal Radiol 2010; 39 (1): 79–83Liu TY, Lin WC, Huang LY, Chen SY, Yang MC. Hemocompatibility and anaphylatoxin formation of protein-immobilizing polyacrylonitrile hemodialysis membrane. Skeletal Radiol 2010; 39 (1): 79–83Martello M, Di Luca M. Acetate-free biofiltration. G Ital Nefrol 2012; 29 [Suppl 55]: 62–71Martello M, Di Luca M. Acetate-free biofiltration. G Ital Nefrol 2012; 29 [Suppl 55]: 62–71Matsuda K, Moriguchi T, Harii N, Yanagisawa M, Harada D, Sugawara H. Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure. Contrib Nephrol 2011; (173): 182-190Matsuda K, Moriguchi T, Harii N, Yanagisawa M, Harada D, Sugawara H. Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure. Contrib Nephrol 2011; (173): 182-190Nakano A. Ethylene vinyl alcohol co-polymer as a highperformance membrane: an EVOH membrane with excellentbiocompatibility. Contrib Nephrol 2011; (173): 164–167Nakano A. Ethylene vinyl alcohol co-polymer as a highperformance membrane: an EVOH membrane with excellentbiocompatibility. Contrib Nephrol 2011; (173): 164–167Nasr R, Saifan C, Barakat I, Azzi YA, Naboush A, Saad M, Sayegh SE. Relationship between platelet count and hemodialysis membranes. Int J Nephrol Renovasc Dis 2013; 14 (6): 143–147Nasr R, Saifan C, Barakat I, Azzi YA, Naboush A, Saad M, Sayegh SE. Relationship between platelet count and hemodialysis membranes. Int J Nephrol Renovasc Dis 2013; 14 (6): 143–147Nusair MB, Rajpurohit N, Alpert MA. Chronic Inflammation and Coronary Atherosclerosis in Patients with End-Stage Renal Disease. Cardiorenal Med 2012; (2): 117–124Nusair MB, Rajpurohit N, Alpert MA. Chronic Inflammation and Coronary Atherosclerosis in Patients with End-Stage Renal Disease. Cardiorenal Med 2012; (2): 117–124Olafiranye F, Kyaw W, Olafiranye O. Resolution of dialyzer membrane-associated thrombocytopenia with use of cellulose triacetate membrane: a case report. Case Rep Med 2011; 20 (11): 134–145Olafiranye F, Kyaw W, Olafiranye O. Resolution of dialyzer membrane-associated thrombocytopenia with use of cellulose triacetate membrane: a case report. Case Rep Med 2011; 20 (11): 134–145Palmer SC, Rabindranath KS, Craig JC, Roderick PJ, Locatelli F, Strippoli GF. High-flux versus low-flux membranes for end-stage kidney disease. Cochrane Database Syst Rev 2012; 12 (9): CD005016 pub 2Palmer SC, Rabindranath KS, Craig JC, Roderick PJ, Locatelli F, Strippoli GF. High-flux versus low-flux membranes for end-stage kidney disease. Cochrane Database Syst Rev 2012; 12 (9): CD005016 pub 2Panichi V, Rizza GM, Paoletti S, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008; 17 (23): 2337–2343.Panichi V, Rizza GM, Paoletti S, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008; 17 (23): 2337–2343.Piroddi M, Pilolli F, Aritomi M, Galli F. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes. Am J Nephrol 2012; 35 (6): 559–572Piroddi M, Pilolli F, Aritomi M, Galli F. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes. Am J Nephrol 2012; 35 (6): 559–572Poon PY, Szeto CC, Kwan BC, et al. Relationship between serum levels of tumour necrosis factor-related apoptosis-inducing ligand and the survival of Chinese peritoneal dialysis patients. Nephrology (Carlton) 2012; 25 (17): 466–471Poon PY, Szeto CC, Kwan BC, et al. Relationship between serum levels of tumour necrosis factor-related apoptosis-inducing ligand and the survival of Chinese peritoneal dialysis patients. Nephrology (Carlton) 2012; 25 (17): 466–471Post JB. Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report. Am J Kidney Dis 2010; 55 (6): 25–28Post JB. Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report. Am J Kidney Dis 2010; 55 (6): 25–28Puchades MJ, Saez G, Muñoz MC, Gonzalez M, Torregrosa I, Juan I, Miguel A. Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clin Nephrol 2013; 80 (9): 177–186Puchades MJ, Saez G, Muñoz MC, Gonzalez M, Torregrosa I, Juan I, Miguel A. Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clin Nephrol 2013; 80 (9): 177–186Rao M, Jaber BL, Balakrishnan VS. Inflammatory biomarkers and cardiovascular risk: association or cause and effect? Semin Dial 2006; 28 (19): 129–135Rao M, Jaber BL, Balakrishnan VS. Inflammatory biomarkers and cardiovascular risk: association or cause and effect? Semin Dial 2006; 28 (19): 129–135Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 4 (98): 731–733Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 4 (98): 731–733Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; (344): 1959–1965Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; (344): 1959–1965Sakai Y. Polymethylmethacrylate membrane with a series of serendipity. Contrib Nephrol 2011; (173): 137-147Sakai Y. Polymethylmethacrylate membrane with a series of serendipity. Contrib Nephrol 2011; (173): 137-147Sawires HK, Mohamed WA, Schaalan MF. High-flux and low-flux dialysis membranes and levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with chronic kidney failure. Iran J Kidney Dis 2012; 6 (5): 366–372Sawires HK, Mohamed WA, Schaalan MF. High-flux and low-flux dialysis membranes and levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with chronic kidney failure. Iran J Kidney Dis 2012; 6 (5): 366–372Scand J. Traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Urol Nephrol. 2004; (38): 405–416Scand J. Traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Urol Nephrol. 2004; (38): 405–416Senthilkumar S, Rajesh S, Jayalakshmi A, Mohan D. Biocompatibility studies of polyacrylonitrile membranes modified with carboxylatedpolyetherimide. Mater Sci Eng C Mater Biol Appl 2013; 33 (7): 3615–3626Senthilkumar S, Rajesh S, Jayalakshmi A, Mohan D. Biocompatibility studies of polyacrylonitrile membranes modified with carboxylatedpolyetherimide. Mater Sci Eng C Mater Biol Appl 2013; 33 (7): 3615–3626Shtilman MI. Immobilzation on polymer. VSP. Utrecht – Tpkyo., 1993; 3–496Shtilman MI. Immobilzation on polymer. VSP. Utrecht – Tpkyo., 1993; 3–496Shum HP, Chan KC, Kwan MC, Yan WW. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection. Hong Kong Med J 2013; 3 (12): 320–327Shum HP, Chan KC, Kwan MC, Yan WW. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection. Hong Kong Med J 2013; 3 (12): 320–327Sniderman AD, Solhpour A, AlamA , Williams K, Sloand JA. Cardiovascular death in dialysis patients: lessons we can learn from AURORA. Clin J Am Soc Nephrol 2010; (5): 335–340Sniderman AD, Solhpour A, AlamA , Williams K, Sloand JA. Cardiovascular death in dialysis patients: lessons we can learn from AURORA. Clin J Am Soc Nephrol 2010; (5): 335–340Stanković-Popović V, Popović D, Dimković N, Maksić D, Vasilijić S, Colić M, Vucinić Z, Radjen S, Milicić B. Influence of peritoneal dialysis solution biocompatibility on long-term survival of patients on continuous ambulatory peritoneal dialysis and the technique itself. Vojnosanit Pregl 2013; 70 (4): 352– 362Stanković-Popović V, Popović D, Dimković N, Maksić D, Vasilijić S, Colić M, Vucinić Z, Radjen S, Milicić B. Influence of peritoneal dialysis solution biocompatibility on long-term survival of patients on continuous ambulatory peritoneal dialysis and the technique itself. Vojnosanit Pregl 2013; 70 (4): 352– 362Taylor SP, Taylor BT. Healthcare-associated pneumonia in hemodialysis patients: Clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy. Respirology 2012; 5 (12): 243–250Taylor SP, Taylor BT. Healthcare-associated pneumonia in hemodialysis patients: Clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy. Respirology 2012; 5 (12): 243–250Urbani A, Lupisella S, Sirolli V, Bucci S, Amoroso L, Pavone B, Pieroni L, Sacchetta P, Bonomini M. Proteomic analysis of protein adsorption capacity of different haemodialysis membranes. Mol Biosyst 2012; 8 (4): 1029–1039Urbani A, Lupisella S, Sirolli V, Bucci S, Amoroso L, Pavone B, Pieroni L, Sacchetta P, Bonomini M. Proteomic analysis of protein adsorption capacity of different haemodialysis membranes. Mol Biosyst 2012; 8 (4): 1029–1039Williams D. The role of nitric oxide in biocompatibility. Med Device Technol 2008; 19 (7): 8–10Williams D. The role of nitric oxide in biocompatibility. Med Device Technol 2008; 19 (7): 8–10Yoo HH, Martin LC, Kochi AC, et al. Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension? BMC Nephrol 2012; (13): 80–85Yoo HH, Martin LC, Kochi AC, et al. Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension? BMC Nephrol 2012; (13): 80–85Басов НИ, Земсков ВН. Комплемент и его роль в регуляции иммунологических реакций. Успехи соврем биол 1982; (24): 51–58Басов НИ, Земсков ВН. Комплемент и его роль в регуляции иммунологических реакций. Успехи соврем биол 1982; (24): 51–58Валуев ЛИ. Итоги науки и техники [Химия и технология высокомолекулярных соединений. Т. 16], pед. Н.А. Платэ, ВИНИТИ, М., 1976; 3–210Валуев ЛИ. Итоги науки и техники [Химия и технология высокомолекулярных соединений. Т. 16], pед. Н.А. Платэ, ВИНИТИ, М., 1976; 3–210Васильев АН, Губарь НЯ, Смирнов АВ, Суглобова ЕД. Опыт применения предилюционной онлайн гемодиафильтрации у больных с терминальной почечной недостаточностью. Нефрология 2008; 4 (12): 18–25Васильев АН, Губарь НЯ, Смирнов АВ, Суглобова ЕД. Опыт применения предилюционной онлайн гемодиафильтрации у больных с терминальной почечной недостаточностью. Нефрология 2008; 4 (12): 18–25Даугирдас ДТ, Блейк ПД, Инг ТС. Руководство по диализу. 3-е изд., Триада, Тверь, 2003; 6–386Даугирдас ДТ, Блейк ПД, Инг ТС. Руководство по диализу. 3-е изд., Триада, Тверь, 2003; 6–386Жозефович М, Жозефонвич ЖЖ. Полимерные материалы. Всес Химич Общ 1985; 30 (4): 410–419Жозефович М, Жозефонвич ЖЖ. Полимерные материалы. Всес Химич Общ 1985; 30 (4): 410–419Зорчева РИ, Икономов ВХ, Паскалев ДН. Онлайн гемодиафильтрация и удаление фосфатов у больных с терминальной почечной недостаточностью, получающих лечение гемодиализом. Нефрология 2013; 1 (17): 9–14Зорчева РИ, Икономов ВХ, Паскалев ДН. Онлайн гемодиафильтрация и удаление фосфатов у больных с терминальной почечной недостаточностью, получающих лечение гемодиализом. Нефрология 2013; 1 (17): 9–14Зубаиров ДМ. Биохимия свертывания крови. Медицина, М., 1978; 3–58Зубаиров ДМ. Биохимия свертывания крови. Медицина, М., 1978; 3–58Казарян ПА, Баблоян АС, Егиазарян КВ. Мембранные аспекты патогенеза терминальной почечной недостаточности. Нефрология 2008; 4 (12): 26–31Казарян ПА, Баблоян АС, Егиазарян КВ. Мембранные аспекты патогенеза терминальной почечной недостаточности. Нефрология 2008; 4 (12): 26–31Килстейн ЯТ, Флизер Д. Продленный ежедневный диализ. Нефрология 2008; 2 (12): 5–15Килстейн ЯТ, Флизер Д. Продленный ежедневный диализ. Нефрология 2008; 2 (12): 5–15Кузнецов АЮ, Петров АК, Макрянский ВА. Синтетические полимеры медицинского назначения. Тез Всес симпоз. 1989; (1): 103–104Кузнецов АЮ, Петров АК, Макрянский ВА. Синтетические полимеры медицинского назначения. Тез Всес симпоз. 1989; (1): 103–104Перепечко ИИ. Введение в физику полимеров. Химия, М., 1978; 5–312Перепечко ИИ. Введение в физику полимеров. Химия, М., 1978; 5–312Полухина ЕВ, Москаленко НВ, Канин ЕС и др. Случай выраженной метастатической кальцификации периаортикулярных тканей у пациента на хроническом гемодиализе. Нефрология 2013; 4 (17): 23–27Полухина ЕВ, Москаленко НВ, Канин ЕС и др. Случай выраженной метастатической кальцификации периаортикулярных тканей у пациента на хроническом гемодиализе. Нефрология 2013; 4 (17): 23–27Разъяснение для использования территориальными органами ФАС России при определении товарных границ рынка медицинского оборудования и рынка расходных материалов для гемодиализа, 2009 г.Разъяснение для использования территориальными органами ФАС России при определении товарных границ рынка медицинского оборудования и рынка расходных материалов для гемодиализа, 2009 г.Севастьянов ВИ, Ласкина ОВ, Новикова СП, и др. Современные гемосовместимые материалы для сердечнососудистой хирургии. В: Шумаков ВИ, ред. ВНИИМИ, М., 1987; 3–73Севастьянов ВИ, Ласкина ОВ, Новикова СП, и др. Современные гемосовместимые материалы для сердечнососудистой хирургии. В: Шумаков ВИ, ред. ВНИИМИ, М., 1987; 3–73Севастьянов ВИ. Биоматериалы медицинского назначения. Трансплантология и искусственные органы. Тезисы докладов I Всероссийского съезда по трансплантологии и искусственным органам (Москва, 8–10 октября 1998 г.). М., 1998; 100Севастьянов ВИ. Биоматериалы медицинского назначения. Трансплантология и искусственные органы. Тезисы докладов I Всероссийского съезда по трансплантологии и искусственным органам (Москва, 8–10 октября 1998 г.). М., 1998; 100Севастьянов ВИ. Биосовместимость. Медицина, М., 1999; 4–368Севастьянов ВИ. Биосовместимость. Медицина, М., 1999; 4–368Смурова ЕВ, Доброва НВ. Итоги науки и техники (Серия: Химия и технология высокомолекулярных соединений). ВИНИТИ, М., 1976; 3–60Смурова ЕВ, Доброва НВ. Итоги науки и техники (Серия: Химия и технология высокомолекулярных соединений). ВИНИТИ, М., 1976; 3–60Уорд АМ, Уичер ДжТ. Иммунохимия в клинической лабораторной практике. Медицина, М., 1981; 3–236Уорд АМ, Уичер ДжТ. Иммунохимия в клинической лабораторной практике. Медицина, М., 1981; 3–236Штильман МИ. Полимеры медико-биологического назначения. ИКЦ Академкнига, М., 2006; 5–400Штильман МИ. Полимеры медико-биологического назначения. ИКЦ Академкнига, М., 2006; 5–400Шумаков ВИ. Искусственные органы. Медицина, М., 1990; 4–80Шумаков ВИ. Искусственные органы. Медицина, М., 1990; 4–80Яковенко АА, Яковлев ВД, Асанина ЮЮ, Кучер АГ. Роль хронического воспаления в патогенезе «уремической недостаточности питания» у пациентов с терминальной почечной недостаточностью, получающих лечение хроническим гемодиализом. Нефрология 2009; 1 (13): 20–24Яковенко АА, Яковлев ВД, Асанина ЮЮ, Кучер АГ. Роль хронического воспаления в патогенезе «уремической недостаточности питания» у пациентов с терминальной почечной недостаточностью, получающих лечение хроническим гемодиализом. Нефрология 2009; 1 (13): 20–24

The authors declare that there are no conflicts of interest present.